Revelation Biosciences Forms Acute Kidney Injury Advisory Board

The clinical-stage life sciences company aims to develop innovative solutions for acute and chronic diseases.

Apr. 6, 2026 at 3:36pm

Got story updates? Submit your updates here. ›

A ghostly, translucent X-ray photograph of a human kidney, revealing its intricate internal structure in shades of white and grey against a dark background.Revelation Biosciences' new advisory board will guide the company's efforts to develop innovative treatments for acute kidney injury, a serious condition that can lead to long-term damage if not properly addressed.San Diego Today

Revelation Biosciences, Inc., a clinical-stage life sciences company, has announced the formation of an Acute Kidney Injury (AKI) Advisory Board to support the development of innovative solutions for acute and chronic diseases. The company is preparing to initiate a Phase I clinical trial for its AKI treatment.

Why it matters

Acute kidney injury is a serious and common condition that can lead to long-term health problems if not properly treated. The formation of this advisory board demonstrates Revelation Biosciences' commitment to advancing research and finding new ways to address this important healthcare challenge.

The details

Revelation Biosciences, a NASDAQ-listed company, is developing innovative solutions to treat acute and chronic diseases. The company has now established an Acute Kidney Injury (AKI) Advisory Board to provide guidance and expertise as it prepares to initiate a Phase I clinical trial for its AKI treatment.

  • Revelation Biosciences announced the formation of the AKI Advisory Board on April 6, 2026.

The players

Revelation Biosciences, Inc.

A clinical-stage life sciences company developing innovative solutions to treat acute and chronic diseases.

Got photos? Submit your photos here. ›

What’s next

Revelation Biosciences is preparing to initiate a Phase I clinical trial for its AKI treatment, with the guidance of the newly formed AKI Advisory Board.

The takeaway

The formation of the Acute Kidney Injury Advisory Board demonstrates Revelation Biosciences' commitment to advancing research and finding new solutions to address this important healthcare challenge.